Selexis empowers scientists and biopharmaceutical companies around the world to realize the full potential of their work.

Who we are

Selexis SA is the global leader in mammalian cell line development, providing the highly specialized technology and expertise that are needed to translate scientific innovation into life-saving medicines.

SUREtechnology Platform

With more than 100 partners worldwide, 80+ drug products in clinical development and three commercial products utilizing Selexis-generated cell lines, the Company has a history of empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research.

LOREM IPSUM

RECENT AND UPCOMING EVENTS

September 20, 2017
BioAlps 4à6 Event at Selexis Headquarters | Geneva, Switzerland

September 25-28, 2017
BioProcess International Conference | Boston, USA

November 6-8, 2017
BIO-Europe | Berlin, Germany

November 13-17, 2017
PEGS Europe | Lisbon, Portugal

January 8-11, 2018
J.P. Morgan 36th Annual Healthcare Conference | San Francisco, USA

January 8-12, 2018
PEPTALK | San Diego, USA



We are Social